MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Press releases

Stay current with the latest press releases from within the industry.

Dr. Peter Cadieux named to research chair

Release issued 8th July 2009

Lawson Health Research Institute today announced Dr. Peter Cadieux, has been selected the inaugural Miriam Burnett Research Chair in Urological Sciences. Cadieux is an Assistant Professor in the Departments of Surgery (Division of Urology) and Microbiology and Immunology at the Schulich School of Medicine & Dentistry and a Scientist at Lawson.


"I plan to use my research knowledge and experience to bring together several key, clinically-relevant research areas including bacterial infections, bladder cancer and probiotics," says Cadieux. "Currently, our research group has collaborations with basic scientists, clinicians and industrial partners both nationally and internationally, and through this position I seek to expand this network to further our research goals."


Dr. Cadieux's research background includes work on prostate cancer, probiotics, device-related urinary tract infections, bacterial biofilms and kidney stone disease. As Chair, he plans to focus his research on two major areas: bacterial biofilms in urology and the role of microbes in bladder cancer development, prevention and treatment. "Both areas will have a solid probiotic component to them as well", adds Cadieux. "Numerous studies have already demonstrated the ability of probiotic organisms to inhibit pathogenic biofilms and prevent bladder tumour recurrence, and we plan to identify specific mechanisms involved in these health benefits."

The chair is funded by The W. Garfield Weston Foundation and the late Mrs. Miriam Burnett.

 

Company details

If you want to find out more about the company visit WORLDiscoveries profile.

Latest WORLDiscoveries press releases

More Press Releases

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us